Study Of Sunitinib Malate Versus Sorafenib In Patients With Inoperable Liver Cancer

Clinical trial NCT00699374 · TERMINATED

Trial details

NCT number: NCT00699374
Sponsor: Pfizer
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Carcinoma, Hepatocellular

Start date: 2008-07-01
Primary completion: 2011-12-01
Enrollment: 1075

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.